These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 28353142)
1. Analysis of Species-Selectivity of Human, Mouse and Rat Cytochrome P450 1A and 2B Subfamily Enzymes using Molecular Modeling, Docking and Dynamics Simulations. Karthikeyan BS; Suvaithenamudhan S; Akbarsha MA; Parthasarathy S Cell Biochem Biophys; 2018 Jun; 76(1-2):91-110. PubMed ID: 28353142 [TBL] [Abstract][Full Text] [Related]
2. Modelling species selectivity in rat and human cytochrome P450 2D enzymes. Edmund GH; Lewis DF; Howlin BJ PLoS One; 2013; 8(5):e63335. PubMed ID: 23691026 [TBL] [Abstract][Full Text] [Related]
3. Homology modeling and molecular dynamics of CYP1A1 and CYP2B1 to explore the metabolism of aryl derivatives by docking and experimental assays. Rosales-Hernández MC; Mendieta-Wejebe JE; Trujillo-Ferrara JG; Correa-Basurto J Eur J Med Chem; 2010 Nov; 45(11):4845-55. PubMed ID: 20813430 [TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences. Lewis DF; Ito Y; Lake BG J Enzyme Inhib Med Chem; 2010 Oct; 25(5):679-84. PubMed ID: 20100069 [TBL] [Abstract][Full Text] [Related]
5. Ensemble modeling of substrate binding to cytochromes P450: analysis of catalytic differences between CYP1A orthologs. Prasad JC; Goldstone JV; Camacho CJ; Vajda S; Stegeman JJ Biochemistry; 2007 Mar; 46(10):2640-54. PubMed ID: 17300179 [TBL] [Abstract][Full Text] [Related]
6. Characterization of differences in substrate specificity among CYP1A1, CYP1A2 and CYP1B1: an integrated approach employing molecular docking and molecular dynamics simulations. Kesharwani SS; Nandekar PP; Pragyan P; Rathod V; Sangamwar AT J Mol Recognit; 2016 Aug; 29(8):370-90. PubMed ID: 26916064 [TBL] [Abstract][Full Text] [Related]
7. Investigation of ligand selectivity in CYP3A7 by molecular dynamics simulations. Fan JR; Zheng QC; Cui YL; Li WK; Zhang HX J Biomol Struct Dyn; 2015; 33(11):2360-7. PubMed ID: 26065334 [TBL] [Abstract][Full Text] [Related]
8. Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date. Sridhar J; Goyal N; Liu J; Foroozesh M Molecules; 2017 Jul; 22(7):. PubMed ID: 28698457 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of human and rat CYP1A1 enzyme by grapefruit juice compounds. Santes-Palacios R; Romo-Mancillas A; Camacho-Carranza R; Espinosa-Aguirre JJ Toxicol Lett; 2016 Sep; 258():267-275. PubMed ID: 27444380 [TBL] [Abstract][Full Text] [Related]
10. Structural and energetic analysis to provide insight residues of CYP2C9, 2C11 and 2E1 involved in valproic acid dehydrogenation selectivity. Bello M; Mendieta-Wejebe JE; Correa-Basurto J Biochem Pharmacol; 2014 Jul; 90(2):145-58. PubMed ID: 24794636 [TBL] [Abstract][Full Text] [Related]
11. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. Venhorst J; ter Laak AM; Commandeur JN; Funae Y; Hiroi T; Vermeulen NP J Med Chem; 2003 Jan; 46(1):74-86. PubMed ID: 12502361 [TBL] [Abstract][Full Text] [Related]
12. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1. Jerabek P; Martinek V; Stiborova M Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840 [TBL] [Abstract][Full Text] [Related]
13. A Highly Selective Ratiometric Two-Photon Fluorescent Probe for Human Cytochrome P450 1A. Dai ZR; Ge GB; Feng L; Ning J; Hu LH; Jin Q; Wang DD; Lv X; Dou TY; Cui JN; Yang L J Am Chem Soc; 2015 Nov; 137(45):14488-95. PubMed ID: 26488456 [TBL] [Abstract][Full Text] [Related]
14. Interactions of 2-phenyl-benzotriazole xenobiotic compounds with human Cytochrome P450-CYP1A1 by means of docking, molecular dynamics simulations and MM-GBSA calculations. Mena-Ulecia K; MacLeod-Carey D Comput Biol Chem; 2018 Jun; 74():253-262. PubMed ID: 29677600 [TBL] [Abstract][Full Text] [Related]
15. Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6. Ellis SW; Hayhurst GP; Lightfoot T; Smith G; Harlow J; Rowland-Yeo K; Larsson C; Mahling J; Lim CK; Wolf CR; Blackburn MG; Lennard MS; Tucker GT Biochem J; 2000 Feb; 345 Pt 3(Pt 3):565-71. PubMed ID: 10642515 [TBL] [Abstract][Full Text] [Related]
16. Insight into the effects of chiral isomers quinidine and quinine on CYP2D6 inhibition. Ai C; Li Y; Wang Y; Chen Y; Yang L Bioorg Med Chem Lett; 2009 Feb; 19(3):803-6. PubMed ID: 19103487 [TBL] [Abstract][Full Text] [Related]
17. Molecular docking and molecular dynamics studies reveal structural basis of inhibition and selectivity of inhibitors EGCG and OSU-03012 toward glucose regulated protein-78 (GRP78) overexpressed in glioblastoma. Bhattacharjee R; Devi A; Mishra S J Mol Model; 2015 Oct; 21(10):272. PubMed ID: 26419972 [TBL] [Abstract][Full Text] [Related]
18. Characterization of chicken cytochrome P450 1A4 and 1A5: inter-paralog comparisons of substrate preference and inhibitor selectivity. Yang J; An J; Li M; Hou X; Qiu X Comp Biochem Physiol C Toxicol Pharmacol; 2013 May; 157(4):337-43. PubMed ID: 23474502 [TBL] [Abstract][Full Text] [Related]
19. In vivo induction and in vitro inhibition of hepatic cytochrome P450 activity by the benzodiazepine anticonvulsants clonazepam and diazepam. Nims RW; Prough RA; Jones CR; Stockus DL; Dragnev KH; Thomas PE; Lubet RA Drug Metab Dispos; 1997 Jun; 25(6):750-6. PubMed ID: 9193878 [TBL] [Abstract][Full Text] [Related]
20. Species difference in the induction of hepatic CYP1A subfamily enzymes, especially CYP1A2, by 2-methoxy-4-nitroaniline among rats, mice, and guinea pigs. Souma S; Sekimoto M; Degawa M Arch Toxicol; 2006 Nov; 80(11):739-47. PubMed ID: 16639589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]